Inspire Medical Systems
INSP
76 hedge funds and large institutions have $337M invested in Inspire Medical Systems in 2018 Q2 according to their latest regulatory filings, with 76 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
44.38% more ownership
Funds ownership: 0% → 44.38% (+44%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$78.9M |
| 2 |
Millennium Management
New York
|
+$24.2M |
| 3 |
TCM
TimesSquare Capital Management
New York
|
+$21.3M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$18.7M |
| 5 |
BlackRock
New York
|
+$17.8M |
Top Sellers
INSP Hedge Fund Activity: Q2 2018 in Review
76 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Inspire Medical Systems (INSP) for Q2 2018, worth a combined $337M.
Buyers outnumbered sellers: 76 funds opened new INSP positions and 0 closed out — a net gain of 76 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was OrbiMed, opening a new position worth an estimated $78.9M.
- 76 institutional investors held Inspire Medical Systems (INSP) as of Q2 2018, up from 0 in Q1 2018.
- Funds reported $337M of Inspire Medical Systems stock for Q2 2018.
- 76 funds opened new Inspire Medical Systems positions in Q2 2018 and 0 closed out, a net change of +76 holders.
- The largest Inspire Medical Systems buyer in Q2 2018 was OrbiMed, an estimated $78.9M added.
Based on aggregated 13F filings for Q2 2018.